anmelden
NYSE International 100
10.919,14
PKT
+156,25
PKT
+1,45
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NYSE International 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.04.22 | SAP Buy | Goldman Sachs Group Inc. | |
| 12.04.22 | Santander Neutral | JP Morgan Chase & Co. | |
| 12.04.22 | Allianz Buy | Jefferies & Company Inc. | |
| 12.04.22 | SAP Buy | Baader Bank | |
| 12.04.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 12.04.22 | AXA Buy | Goldman Sachs Group Inc. | |
| 12.04.22 | ING Group Sector Perform | RBC Capital Markets | |
| 12.04.22 | Deutsche Telekom Buy | Goldman Sachs Group Inc. | |
| 12.04.22 | ING Group Buy | UBS AG | |
| 12.04.22 | Vodafone Group Buy | UBS AG | |
| 12.04.22 | Prudential Buy | UBS AG | |
| 12.04.22 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.04.22 | HSBC Neutral | Credit Suisse Group | |
| 12.04.22 | Diageo Overweight | JP Morgan Chase & Co. | |
| 12.04.22 | ING Group Outperform | Credit Suisse Group | |
| 12.04.22 | Siemens Overweight | JP Morgan Chase & Co. | |
| 12.04.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 12.04.22 | Santander Neutral | JP Morgan Chase & Co. | |
| 11.04.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 11.04.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 11.04.22 | Barclays Outperform | Credit Suisse Group | |
| 11.04.22 | GSK Neutral | UBS AG | |
| 11.04.22 | Mercedes-Benz Group (ex Daimler) Hold | Jefferies & Company Inc. | |
| 11.04.22 | Sanofi Outperform | Bernstein Research | |
| 11.04.22 | Rio Tinto Buy | Goldman Sachs Group Inc. | |
| 11.04.22 | Santander Buy | Jefferies & Company Inc. | |
| 08.04.22 | Santander Sector Perform | RBC Capital Markets | |
| 08.04.22 | Diageo Buy | Merrill Lynch & Co., Inc. | |
| 08.04.22 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 08.04.22 | AstraZeneca Outperform | Credit Suisse Group | |
| 08.04.22 | Novartis Neutral | UBS AG | |
| 08.04.22 | Sanofi Buy | UBS AG | |
| 08.04.22 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 07.04.22 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 07.04.22 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 07.04.22 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 07.04.22 | TotalEnergies Sector Perform | RBC Capital Markets | |
| 07.04.22 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 07.04.22 | Eni Outperform | RBC Capital Markets | |
| 07.04.22 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets |